Preclinical Pharmacology Characterization of Sovleplenib (HMPL-523), an Orally Available Syk Inhibitor
Yu Cai, Jianlin He, Zhipeng Wu, Weigang He, Xiaoming Dai, Yan Xu, Min Cheng, Na Yang, Yongxin Ren, Guanglin Wang, Jian Wang, Yang Sai, Hong Jia, Guangxiu Dai, Xiong Li, Weiguo Su
Topics & Concepts
SykMedicineImmune systemImmunologyCancer researchPharmacologyB cellAutoimmune diseaseReceptorTyrosine kinaseAntibodyInternal medicineMast cells and histamineMonoclonal and Polyclonal Antibodies ResearchPlatelet Disorders and Treatments